- Home
- KMPR vs RXRX Comparison
KMPR vs RXRX Comparison
Compare KMPR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMPR | RXRX |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | KMPR | RXRX |
|---|---|---|
| Price | $29.71 | $3.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $47.50 | $7.50 |
| AVG Volume (30 Days) | 719.4K | ★ 14.1M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | $16.50 |
| Revenue Next Year | $4.07 | $66.44 |
| P/E Ratio | $14.38 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $28.41 | $2.98 |
| 52 Week High | $69.83 | $7.18 |
Technical Indicators
Market Signals| Indicator | KMPR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.98 | 41.20 |
| Support Level | N/A | $2.98 |
| Resistance Level | $32.63 | $5.12 |
| Average True Range (ATR) | 0.88 | 0.20 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 30.41 | 21.51 |
Price Performance
Historical ComparisonAbout KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.